Mirae Asset Global ETFs Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$851K	Buy	56,396 +1,209	+2%	+$21.1K	﹤0.01%	1722
2026 Q1	$1.06M	Sell	55,187 -6,256	-10%	-$136K	﹤0.01%	1497
2025 Q4	$1.35M	Sell	61,443 -1,255	-2%	-$22.6K	﹤0.01%	1354
2025 Q3	$761K	Sell	62,698 -940	-1%	-$12.7K	﹤0.01%	1654
2025 Q2	$1.19M	Sell	63,638 -10,775	-14%	-$213K	﹤0.01%	1366
2025 Q1	$1.43M	Buy	74,413 +2,096	+3%	+$61.3K	﹤0.01%	1313
2024 Q4	$2.6M	Sell	72,317 -7,554	-9%	-$256K	0.01%	990
2024 Q3	$3.39M	Buy	79,871 +30,935	+63%	+$1.31M	0.01%	890
2024 Q2	$1.97M	Buy	+48,936	New	+$2.04M	﹤0.01%	1084

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TNDM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tandem Diabetes Care (TNDM) stake by 2.2% in Q2 2026, buying an estimated $21.1K and bringing the position to 56,396 shares worth $851K. The position accounts for ﹤0.01% of the portfolio, ranked #1722.

Mirae Asset Global ETFs Holdings first reported a position in TNDM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.39M in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Mirae Asset Global ETFs Holdings held 56,396 shares of Tandem Diabetes Care worth $851K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,209 Tandem Diabetes Care shares in Q2 2026, an estimated $21.1K.
Tandem Diabetes Care made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1722 holding.
Mirae Asset Global ETFs Holdings first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Tandem Diabetes Care position peaked at $3.39M in Q3 2024.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.